The 2026 European Association of Urology (EAU) annual meeting featured a managing advanced disease in renal and rare cancer ...

Prescriber treatment patterns for tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin (mTOR) inhibitors in patients with renal cell carcinoma.

Exploiting Rules to Enhance Machine Learning in Extracting Information From Multi-Institutional Prostate Pathology Reports Applications of deep learning to histopathology have proven capable of expert ...

A 76-year-old woman presented to the emergency department after seeing blood in her urine. She explained that this had been going on since the previous day, when she also began to experience episodes ...

Lung metastases are most common in clear cell renal cell carcinoma, whereas lymph node metastases and liver metastases occur most frequently in papillary and chromophobe RCC, respectively, ...